Related Experiment Video
Updated: Aug 7, 2026
11:09
Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
Published on: July 13, 2010
Survival analysis in clinical trials: past developments and future directions
1Department of Biostatistics, Box 357232, University of Washington, Seattle, Washington 98195, USA. fleming@biostat.washington.edu
Biometrics
|December 29, 2000
Summary
Survival analysis, crucial for clinical trials, includes key methods like Kaplan-Meier estimation and Cox proportional hazards models. Further developments are expected in areas like causal inference and Bayesian methods.
Area of Science:
- Statistics
- Biostatistics
- Clinical Trials
Background:
- Survival analysis emerged in the 20th century, with significant growth in the latter half.
- Key methods impacting clinical trials include Kaplan-Meier, log-rank statistic, and Cox proportional hazards models.
Purpose of the Study:
- To provide an overview of the historical development and foundational methods in survival analysis.
- To highlight the unifying framework provided by counting-process martingale theory.
- To identify areas of ongoing research and future development in survival analysis.
Main Methods:
- Kaplan-Meier method for survival function estimation.
- Log-rank statistic for comparing survival distributions.
- Cox proportional hazards model for covariate effects.
- Counting-process martingale theory for statistical properties.
Main Results:
- Established foundational methods (Kaplan-Meier, log-rank, Cox models) have profoundly impacted clinical trials.
- Counting-process martingale theory offers a unified framework for survival analysis statistics.
- Significant progress has been made, with ongoing advancements expected.
Conclusions:
- Survival analysis is a dynamic field with a rich history and impactful methods for clinical research.
- The field continues to evolve, with future developments anticipated in advanced statistical techniques and applications.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...